A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition. . . . → Read More: Synthetic Bio Company Goes Public in $2.5B Merger
|
|||||
       |
 Comments are closed  Finance  biotechnology, economics, engineering, entrepreneurs, equity, genomics, investment, IPO, life sciences, merger, pharmaceuticals 
MD Anderson Cancer Center and the Broad Institute are developing a new research platform for better understanding rare types of cancer. . . . → Read More: MD Anderson, Broad Institute Partner on Rare Cancers Comments are closed Joint ventures/collaborations biomedical, cancer, genomics, life sciences, pharmaceuticals, university 
A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA. . . . → Read More: New Biotech Developing Synthetic Long-Term RNA 2 comments - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, pharmaceuticals, venture capital 
As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project is starting to emerge. . . . → Read More: Infographic – Public Money Funds Covid-19 Vaccines One comment - (Comments are closed) Finance biomedical, biotechnology, Covid-19, NIH, pharmaceuticals, statistics 
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer. . . . → Read More: Biotechs Partner on Gene-Edited Cancer Cell Therapies 2 comments - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, Europe, genomics, licensing, life sciences, pharmaceuticals 
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round. . . . → Read More: AI Gene Therapy Platform Gains $100M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, engineering, equity, genomics, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, university, venture capital 
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round. . . . → Read More: Cell Therapy Mfring Company Raises $82M in Venture Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, engineering, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, pharmaceuticals, physical sciences, robotics, software, venture capital 
A synthetic antibody is shown in lab tests to neutralize variants of the SARS-CoV-2 virus, and will be added to an ongoing clinical trial of Covid-19 therapies. . . . → Read More: Antibody Clears Covid-19 Variants, Enters Trial Comments are closed New products biomedical, biotechnology, Canada, clinical trials, Covid-19, FDA, pharmaceuticals, preclinical 
Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries. . . . → Read More: Moderna Supplying 500M Vaccine Doses to Covax Comments are closed Joint ventures/collaborations biomedical, biotechnology, Covid-19, Europe, health care, life sciences, pharmaceuticals |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts